SCHEMBL1935489

SCHEMBL1935489

CCC(CC)C(=O)CC(C)=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.44
USP2 O75604 1/20 0.44
ALDH1A1 P00352 3/20 0.40
TDP1 Q9NUW8 2/20 0.40
MGAM O43451 1/20 0.38
GAA P10253 1/20 0.38
SI P14410 1/20 0.38
MGAM2 Q2M2H8 1/20 0.38
CA2 P00918 6/20 0.37
CA1 P00915 4/20 0.37
MAPK1 P28482 1/20 0.36
HTT P42858 2/20 0.35
SLC1A3 P43003 1/20 0.34
SLC1A2 P43004 1/20 0.34
SLC1A1 P43005 1/20 0.34
NPSR1 Q6W5P4 1/20 0.33
KDM4E B2RXH2 1/20 0.33
KDM6B O15054 1/20 0.33
KDM5C P41229 1/20 0.33
EGLN1 Q9GZT9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Potassium SCHEMBL31652342 0.85 USP2 (0.50) TSHRUSP2TDP1CA2CA1
SCHEMBL14285857 0.85 USP2 (0.50) TSHRUSP2TDP1CA2CA1
SCHEMBL6232266 0.83 MGAM (0.38) ALDH1A1TDP1MGAMGAASI
SCHEMBL29431009 0.82 USP2 (0.39) TSHRUSP2CA2CA1MAPK1
SCHEMBL3964956 0.82 CA2 (0.57) TSHRUSP2ALDH1A1CA2CA1
Acetoacetic Acid SCHEMBL939347 0.82 CA4 (0.36) TSHRUSP2ALDH1A1TDP1MGAM
SCHEMBL28339815 0.82 CA4 (0.36) TSHRUSP2ALDH1A1TDP1MGAM
SCHEMBL22431437 0.80 USP2 (0.34) TSHRUSP2CA2CA1KDM4E
SCHEMBL2494024 0.79 HDAC1 (0.50) TSHRALDH1A1TDP1MGAMGAA
Acetic Acid SCHEMBL8992551 0.79 TSHR (0.41) TSHRUSP2TDP1CA2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240024330-A1 CRF RECEPTOR ANTAGONISTS AND METHODS OF USE NEUROCRINE BIOSCIENCES, INC. (US) 2024-01-25 US disclosed
EP-4203964-A1 CRF RECEPTOR ANTAGONISTS AND METHODS OF USE Neurocrine Biosciences, Inc. (US) 2023-07-05 EP disclosed
WO-2022046905-A1 CRF RECEPTOR ANTAGONISTS AND METHODS OF USE NEUROCRINE BIOSCIENCES, INC. (US) 2022-03-03 WO disclosed
EP-2735581-B1 COMPOSITION AND POLYMER ASAHI CHEMICAL IND (JP) 2021-07-14 EP disclosed
US-9738757-B2 Composition and polymer ASAHI KASEI CHEMICALS CORPORATION (JP) 2017-08-22 US disclosed
US-20160222168-A1 Composition and Polymer ASAHI KASEI CHEMICALS CORPORATION (JP) 2016-08-04 US disclosed
US-9334371-B2 Composition and polymer ASAHI KASEI CHEMICALS CORPORATION (JP) 2016-05-10 US disclosed
US-8808954-B2 Electrophotographic photoconductor, process cartridge including the same, and image forming apparatus including the same KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) 2014-08-19 US disclosed
EP-2735581-A1 COMPOSITION AND POLYMER Asahi Kasei Chemicals Corporation (JP) 2014-05-28 EP disclosed
US-20140121293-A1 Composition and Polymer ASAHI KASEI CHEMICALS CORPORATION (JP) 2014-05-01 US disclosed
US-20120288300-A1 ELECTROPHOTOGRAPHIC PHOTOCONDUCTOR, PROCESS CARTRIDGE INCLUDING THE SAME, AND IMAGE FORMING APPARATUS INCLUDING THE SAME KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) 2012-11-15 US disclosed
US-20110177259-A1 METHOD FOR MANUFACTURING OPTICAL WAVEGUIDE NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2011-07-21 US disclosed
EP-2333596-A1 METHOD FOR MANUFACTURING OPTICAL WAVEGUIDE Nissan Chemical Industries, Ltd. (JP) 2011-06-15 EP disclosed
US-6723487-B2 Method for producing article coated with patterned film and photosensitive composition NIPPON SHEET GLASS CO., LTD. (JP) 2004-04-20 US disclosed
US-20020160298-A1 Method for producing article coated with patterned film and photosensitive composition MINAMI, TSUTOMU (JP) 2002-10-31 US disclosed
EP-1160625-A1 METHOD FOR PRODUCING ARTICLE COATED WITH PATTERNED FILM AND PHOTOSENSITIVE COMPOSITION Nippon Sheet Glass Co., Ltd. (JP) 2001-12-05 EP disclosed
US-4150105-A 3-Ketosteroid antigenic conjugates, their preparation, antibodies and use BIOLOGICAL DEVELOPMENTS, INC. (US) 1979-04-17 US disclosed
US-4061604-A 3-HYDROXY-5-PHOSPHONO-1,2-OXAPHOSPHOLANES CIBA-GEIGY CORPORATION (US) 1977-12-06 US disclosed
US-4051229-A REDUCTION OF ALKALI OR ALKALINE EARTH CHLORATE IN SULFURIC OR HYDROCHLORIC ACID WITH COMPLEX B-DIKETONE-PALLADIUM CATALYST THE JAPAN CARLIT CO., LTD. (JA) 1977-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240024330-A1 CRF RECEPTOR ANTAGONISTS AND METHODS OF USE CRHR1, CRHR2, MC2R TSHR 161/4885USP2 3381/4885ALDH1A1 1243/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.